Cara Kingan, Executive Director of the Cure Coalition, published an op-ed with The Well News on U.S. biomedical research as a priority for national security:

Preserving American biomedical leadership is not just about jobs or market share; it is about whether our children’s medicines are developed under rules we can trust and enforce.

…

The same tools that power lifesaving cures can also be used to threaten populations, disrupt economies and erode our strategic autonomy if they are concentrated in the hands of competitors who do not share our values.

 

That is why the United States must treat biotechnology and biomanufacturing as critical infrastructure, with the same seriousness we apply to cybersecurity and defense.

Read the full op-ed at The Well News.